To further address the specificity of the antibody in the context of human tissue, we performed competition assays with purified CRX protein and show on tissue sections of human retinoblastoma and adjacent uninvolved retina that the immunostaining with the H120 anti-Crx antibody can be completely competed away with 1∶1 molar amounts of purified GST-Crx protein in both normal retina and the retinoblastoma tumor cells (Fig. 2D). This evidence concerns the gene CRX and neoplasm.